Home/Pipeline/SNS812

SNS812

COVID‑19 and other infections

Phase 1Active

Key Facts

Indication
COVID‑19 and other infections
Phase
Phase 1
Status
Active
Company

About Oneness Biotech

Taiwanese biotech delivering Phase 3 wound‑care therapy and a diversified pipeline across dermatology, immunology and metabolism.

View full company profile